# OnCo record harbinger-resolve (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/harbinger-resolve/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "harbinger-resolve" ;
  schema:name "RESOLVE (Harbinger Health)"@en ;
  schema:alternateName "Harbinger Health test"@en, "HarbingerHx"@en, "RESOLVE" ;
  schema:description "Harbinger Health's blood test meant for the weeks between a doctor suspecting cancer and a diagnosis, pointing to where in the body a cancer may be; it is not offered as a screening test for well people."@en ;
  schema:url <https://onco.cc/drugs/harbinger-resolve/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://harbinger-health.com/harbinger-health-establishes-resolve-as-a-new-category-for-cancer-detection/>, <https://clinicaltrials.gov/study/NCT05435066>, <https://clinicaltrials.gov/study/NCT07046260> ;
  onco:status "emerging" ;
  onco:tag "test", "mced", "evidence:insufficient" ;
  onco:modality "Multi-cancer blood test for people with suspected cancer (cell-free DNA methylation)" ;
  onco:technologies <https://onco.cc/technologies/mced/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/methylation-profiling/> ;
  onco:companies <https://onco.cc/companies/harbinger-health/> ;
  onco:trials <https://onco.cc/trials/core-hh/>, <https://onco.cc/trials/procares/> .